Skip to main content
Molecule Holdings Inc. logo

Molecule Holdings Inc. — Investor Relations & Filings

Ticker · MLCL ISIN · CA60855E1097 LEI · 529900E2EB85616O9A84 CSE Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country CA Canada
Listing CSE MLCL

About Molecule Holdings Inc.

https://molecule.ca/

Molecule Holdings Inc. is a licensed producer specializing in the cannabis beverages sector. The company focuses on the production, packaging, and distribution of a portfolio of quality crafted branded cannabis beverages (CIBs). Recognized for its innovation, Molecule also serves as a comprehensive contract manufacturer and co-packer for the consumer packaged goods market. The company provides essential infrastructure, technology, know-how, and licensing capabilities, enabling craft producers to develop and market various consumable cannabis products, including beverages and edibles. Molecule is noted for being an early entrant, having been the first small-cap company fully dedicated to cannabis beverages to receive its specific processing license.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended July 31, 2020. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3001 characters, which is relatively short and consistent with a certification letter rather than a full report.
2020-09-29 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Molecule Holdings Inc. It details a material corporate event: completion of a reverse takeover transaction, name change, share consolidation, listing on the Canadian Securities Exchange, and changes in share capital and management. The form is a regulatory filing used to disclose material changes to shareholders and regulators. It is not an annual or quarterly financial report, audit report, earnings release, or other financial statement. It is a formal disclosure of a significant corporate event, consistent with a Regulatory Filing (RNS) category. The document length (6301 characters) and detailed description of the transaction support this classification rather than a brief announcement or a full report. Therefore, the best fit is Regulatory Filings (RNS).
2020-09-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for the three and nine month periods ended July 31, 2020. It contains detailed financial statements including statements of financial position, operations, changes in equity, cash flows, and notes. The document is unaudited and prepared in accordance with IAS 34, which governs interim financial reporting. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content and format clearly identify it as an interim or quarterly financial report rather than an annual report or other filing type. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2020
2020-09-29 English
Financial statements of RTO acquirer.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for the three and nine months ended July 31, 2020, indicating it is a financial report for a period shorter than a full fiscal year. It contains detailed financial statements including statements of financial position, loss and comprehensive loss, changes in equity, cash flows, and accompanying notes. The document is unaudited and prepared by management, consistent with interim or quarterly reporting. There is no indication that this is an announcement or a certification letter; it contains substantive financial data and analysis. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-09-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three and nine month periods ended July 31, 2020. It references condensed consolidated interim financial statements prepared under IAS 34, which is the standard for interim financial reporting. The content includes detailed discussion of business operations, financial condition, going concern considerations, and recent corporate transactions such as a reverse takeover and private placement financing. The document length is substantial (15,000 characters), indicating it is the full MD&A report rather than a brief announcement. The MD&A is a management report explaining financial results and business trends for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR). 9M 2020
2020-09-29 English
Interim MD&A of an operating entity.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three and nine month periods ended July 31, 2020. It references condensed consolidated interim financial statements prepared under IAS 34, which is the standard for interim financial reporting. The content includes detailed discussion of business overview, corporate developments, financing activities, and other operational details typical of an MD&A. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is an annual report (10-K) or a quarterly earnings release (ER) with only highlights. The MD&A is a management report explaining financial results and business trends for an interim period, consistent with the definition of an Interim / Quarterly Report (IR). Therefore, the appropriate classification is IR with high confidence. 9M 2020
2020-09-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.